CSL has an Environment, Health, Safety and Sustainability (EHS2) Strategic Plan, which ensures its facilities operate to internationally recognised standards. This strategy includes compliance with government regulations and commitments to continuously improve the health and safety of the workforce as well as minimising the impact of our operations on the environment.
Global EHS2 risks are discussed quarterly at the Corporate Risk Management Committee level and presented to the Audit and Risk Management Committee (ARMC) of the Board biannually. A report is provided to the Board of Directors biannually. In addition, employees have regular opportunities to report unsafe conditions and discuss safety with their supervisors/managers.
Targets are set annually through a collaborative process with business leaders and are intended to motivate the company to make progress towards an injury and illness-free workplace. Across all indicators with set targets, and inclusive of sites acquired from the Novartis influenza vaccine business (Liverpool, UK, and Holly Springs, US), CSL exceeded global goals during the reporting period. In addition, we continued our long-standing record of no employee or contractor fatalities and zero safety violations or fines.
Against the prior comparable period, CSL reduced the frequency rate of days lost (12% down) and medical treatment (20% down), while serious injury/illness cases increased (12% up). With no discernible clusters of causation or indications of a trend in type or location of incidents, the lost time injury frequency rate (LTIFR) increased (39%) across the comparable period, which was still below our LTIFR goal.
1 The frequency rate is the number of occurrences of injury or disease for each one million hours worked. LTIFR = lost time injury frequency rate (occurrences that resulted in a fatality or time lost from work of one day/shift or more). DLFR = days lost frequency rate. MTIFR = medical treatment incident frequency rate (occurrences which were not lost-time injuries and for which medical treatment was administered). Contractor injuries are not included. Employee hours have been estimated by each site and the estimation method varies based on region.
2 SIIFR = serious injury/illness frequency rate (an injury or illness that has a major impact or effect on the health of the employee, including 1) loss of consciousness – directly related to injury, 2) amputation, 3) fracture – other than hairline fracture of any bone or non-displaced fracture of a digit, 4) in-patient hospitalisation or hospitalisation for observation that is for three or more days, 5) surgical intervention, and/or 6) continuous impairment). Target goals are yet to be introduced.
3 Figures are inclusive of sites acquired from the Novartis influenza vaccine business (Liverpool, UK, and Holly Springs, US [as from 1 August 2015 to 30 June 2016]).